Faricimab for Chronic Central Serous Chorioretinopathy: A Randomized Sham-Controlled Trial
Clinical trial NCT07681167 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07681167
- Sponsor
- Singapore National Eye Centre
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-12-01
- Primary completion
- 2029-08-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.